uniQure
QURE
#5466
Rank
C$1.79 B
Marketcap
C$28.80
Share price
-4.50%
Change (1 day)
178.86%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -C$0.32 Billion

According to uniQure's latest financial reports the company's current earnings are C$15.75 Million. In 2024 the company made an earning of -C$0.33 Billion, an increase over its 2023 earnings that were of -C$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.32 Billion-3.55%
2024 -C$0.33 Billion-22.65%
2023 -C$0.43 Billion139.01%
2022 -C$0.18 Billion-138.54%
2021 C$0.46 B-335.29%
2020 -C$0.2 Billion13.88%
2019 -C$0.18 Billion49.51%
2018 -C$0.12 Billion4.55%
2017 -C$0.12 Billion12.65%
2016 -C$97.72 Million-9.59%
2015 -C$0.11 Billion66.95%
2014 -C$64.74 Million30.8%
2013 -C$49.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.42 B-3,768.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.16 Billion-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-C$0.28 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-C$0.77 Billion 144.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.60 B-4,149.19%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
C$0.94 B-402.24%๐Ÿ‡บ๐Ÿ‡ธ USA